Resistance to Targeted Therapies in Breast Cancer - - Books - Springer International Publishing AG - 9783319701417 - December 13, 2017
In case cover and title do not match, the title is correct

Resistance to Targeted Therapies in Breast Cancer 1st ed. 2017 edition

Price
$ 150.99
excl. VAT

Ordered from remote warehouse

Expected to be ready for shipping Jul 13 - 17

Our customers say:

14-day return policy in accordance with European consumer protection law
Top ranking on Trustpilot
Add to your iMusic wish list

Not rated yet

We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling).

184 pages, 12 Illustrations, black and white; XV, 184 p. 12 illus.

Media Books     Book
Released December 13, 2017
ISBN13 9783319701417
Publishers Springer International Publishing AG
Pages 184
Dimensions 150 × 220 × 20 mm   ·   462 g
Language German  
Editor Prosperi, Jenifer R.

Mere med samme udgiver